|
FAM114A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.392750E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.963060E-04 |
| Normal-vs-Stage2 |
2.076100E-02 |
| Normal-vs-Stage3 |
3.136000E-02 |
| Normal-vs-Stage4 |
1.276080E-02 |
| Stage1-vs-Stage2 |
8.490800E-01 |
| Stage1-vs-Stage3 |
5.625000E-01 |
| Stage1-vs-Stage4 |
8.350000E-01 |
| Stage2-vs-Stage3 |
7.785600E-01 |
| Stage2-vs-Stage4 |
7.564000E-01 |
| Stage3-vs-Stage4 |
5.561200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66561999999093E-05 |
| Normal-vs-AfricanAmerican |
1.868280E-02 |
| Normal-vs-Asian |
7.998200E-02 |
| Caucasian-vs-AfricanAmerican |
5.39019995304812E-09 |
| Caucasian-vs-Asian |
6.508300E-02 |
| AfricanAmerican-vs-Asian |
3.719900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.242200E-04 |
| Normal-vs-Female |
2.584500E-03 |
| Male-vs-Female |
7.987200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.986230E-01 |
| Normal-vs-Age(41-60Yrs) |
3.987700E-04 |
| Normal-vs-Age(61-80Yrs) |
6.225200E-04 |
| Normal-vs-Age(81-100Yrs) |
6.602400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.054000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.870800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.755600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.402800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.115000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.474600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.128400E-02 |
| Normal-vs-Grade 2 |
1.756040E-03 |
| Normal-vs-Grade 3 |
2.758500E-03 |
| Normal-vs-Grade 4 |
1.066360E-02 |
| Grade 1-vs-Grade 2 |
4.701400E-01 |
| Grade 1-vs-Grade 3 |
5.328800E-01 |
| Grade 1-vs-Grade 4 |
7.966800E-01 |
| Grade 2-vs-Grade 3 |
9.392400E-01 |
| Grade 2-vs-Grade 4 |
4.531200E-01 |
| Grade 3-vs-Grade 4 |
4.923600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.33280000000646E-05 |
| Normal-vs-ccB subtype |
1.193220E-04 |
| ccA subtype-vs-ccB subtype |
6.142800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.430600E-04 |
| Normal-vs-N1 |
6.476200E-02 |
| N0-vs-N1 |
2.026000E-01 |
|
|
